Meetings/Workshops on Oncology in Germany

Der Fokus des ersten Veranstaltungstages liegt im Bereich Diagnostik, während am zweiten Tag die Therapie und Therapiemöglichkeiten in den Mittelpunkt gerückt werden. In Übersichtsvorträgen, geleitet von renommierten Referenten, sollen die neusten Diagnostik- und Therapiemöglichkeiten vorgestellt werden. Dem LHOS vorgeschalten ist ein Diagnostikkurs, der sich an Ärztinnen und Ärzte in Weiterbildung zum Hämatologen/Onkologen, Medizinisch-Technisches Personal und auch an interessierte Mitarbeiter der Pharmaindustrie richtet, die einen umfassenden Überblick zu aktuellen Standards in der Diagnostik von Leukämien und Lymphomen vermittelt bekommen. Neben der Lehrmikroskopie werden Übersichtsvorträge von erfahrenen Hämatologen gehalten sowie interessante Kasuistiken vorgestellt. Der Kurs wird mit einem Zertifikat abgeschlossen und ist mit 26 Weiterbildungspunkten der Kategorie C zertifiziert. Parallel erhalten die Teilnehmer des Diagnostikkurses die Möglichkeit den LHOS ohne zusätzliche Gebühren zu besuchen.

Phone: [+49 (0)341 308884 – 82];     Email: kschmidt@eventlab.org

Hämatologie, Onkologie, Zytogenetik, MRD-Diagnostik, Biomarker, Mantelzelllymphom, Hämostaseologie, Multiples Myelom, Chemotherapie, Schwangerschaft, kolorektales Karzinom

Hematology,    Continuing Medical Education (CME)

Der DKK 2020 steht unter dem Motto informativ. innovativ. integrativ. Optimale Versorgung für alle.

Phone: [+49 3643 2468-0];     Email: info@kukm.de

Deutsche Krebsgesellschaft e. V., Stiftung Deutsche Krebshilfe, Berliner Krebsgesellschaft e. V.

Informationsaustausch über neueste Erkenntnisse rund um das Thema Krebs mit zahlreichen Informationsständen - Erfahrungsaustausch von Experten und Betroffenen über Aktuelles zu den Erkrankungen - Gespräche mit Experten, Selbsthilfeorganisationen sowie anderen Betroffenen und Angehörigen

Deutsche Krebsgesellschaft e. V., Stiftung Deutsche Krebshilfe, Berliner Krebsgesellschaft e. V.;     Phone: [+49 30 3229329-0, +49 228 72990-0, +49 30 28324-00];     Email: service@kfrebsgesellschaft.de, deutsche@krebshilfe.de, info@berliner-krebsgesellschaft.de

Informationsveranstaltung zu aktuellen Erkrankungen wie Brust-, Prostata-, Darm-, Lungen-, Blasen-, Nieren- und Hautkrebs, Leukämie, Lymphome, Hirn- und gynäkologischen Tumoren..., Selbsthilfe, Betroffene, Angehörige, Psychische und soziale Belastungen, Erfahrungsaustausch, Krebskongress

ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic

The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

WMA GmbH Congress Office;     Phone: [+431405138318];     Email: itoc@medacad.org

Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy

Immunology and Allergic Diseases,    Pharmacology and Drug Development

Justus-Liebig-Universität Gießen

We proudly and cordially invite you to the upcoming „4th International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma“ to be held 13-16 May, 2020 in Berlin, Germany. This important symposium has now almost become a tradition for scientists, clinicians, pharmacists, clinical trial staff, and all people who are involved in the science, diagnosis, and treatment of young people with Hodgkin lymphoma. We are putting together, in collaboration with our fantastic Scientific Committee, a high-quality program with renowned international speakers and experts in the field of Hodgkin lymphoma. We will have two and a half days dedicated to ten main Session Topics, who are now open for abstract submission. We will have interactive case discussions as an opener of most session topics. High-level poster presentations will have the opportunity to advertise their poster via poster pitches in the respective main sessions. One of the highlights will be the awarding of the Günther-Schellong-Price, which will be conferred for the third time. The Scientific Symposium will close with the Abstract Award Session. It is our utmost pleasure to serve again with a major symposium for this great global network for advancing the science and development of standards of care for children, adolescents and young adults with Hodgkin lymphoma. Thus, your attendance at the symposium, will contribute for this well-established network to continue, and you will have the chance to experience the spirit and the action that this great collaboration enables in providing long-lasting cures for all children, adolescents and young adults with Hodgkin lymphoma.

Conference office / Registration;     Phone: [+49 40 30770 300];     Email: iscayahl@csihamburg.de

advancing science, advancing development, standards of care for children, adolescents and young adults with Hodgkin lymphoma, Hodgkin lymphoma, diagnosis and treatment of young people with Hodgkin lymphoma

German Cancer Reseach Center Heidleberg (DKFZ) and University Hospital Heidelberg

The fast technological development and the rapid clinical implementation of MRI for radiotherapy applications is currently one of the most exciting as well as most challenging developments in radiation oncology. With this science symposium we would not only like to bring together specialists from all involved disciplines, but also to foster a discussion about the scientific direction of the field. The latest developments in physics and technology of MR-guided radiotherapy as well as clinical directions and results will be presented.

Phone: [+49 6221 423481];     Email: mrinrthd@dkfz-heidelberg.de

MR guidance, image guidance, adaptive radiotherapy, MR imaging, functionall imaging and others

Biophysics, Medical Physics,    Radiology: Nuclear Magnetic Resonance Imaging

Wir freuen uns sehr, Sie zur 3. gemeinsamen Jahrestagung der Mitteldeutschen Gesellschaft für Gastroenterologie (MGG) und der Mitteldeutschen Chirurgenvereinigung (MDCV), dem 3. Mitteldeutschen Pflegesymposium und dem 9. Symposium Junge Chirurgen in Mitteldeutschland in Dresden zu begrüßen. Nach den erfolgreichen gemeinsamen Kongressen 2018 in Leipzig und 2019 in Halle wollen wir das interdisziplinäre Profil des wissenschaftlichen Programms weiter stärken. Gemäß unserem Kongressmotto „Innovationen für die Praxis“ haben wir zeitgemäße Themenschwerpunkte in den Bereichen innovativer operativer und gastroenterologischer Therapien, der Onkologie, bei seltenen und bei entzündlichen Erkrankungen des Gastrointestinaltrakts, sowie dem immer relevanteren metabolischen Syndrom gesetzt. Besonders wichtig ist es uns, die Interessen der jungen Chirurgen und jungen Gastroenterologen in unserem Programm abzubilden. Wir freuen uns auf Ihre zahlreiche Teilnahme in den dezidierten Sitzungen und praktischen Workshops unter anderem in den Bereichen Robotik, Naht und Darmsonographie. Herausragende Leistungen würdigen wir traditionell durch die im Rahmen des Gesellschaftsabends verliehenen Posterpreise. Wir finden, Viszeralmedizin ist Teamwork. Daher steht die Einbeziehung der Pflege mit dem bewährten Pflegesymposium wieder auf dem Programm und soll in interdisziplinären Workshops weiter gestärkt werden.

event lab. GmbH;     Phone: [0341-30888464];     Email: tbaehr@eventlab.org

Gastroenterologie, Chirurgie, Onkologie, Robotik und Digitalisierung, Darmsonographie, Naht, Viszeralmedizin, Kolorektales Karzinom, Pankreaskarzinom, Leberversagen, CED, Endoskopische Innovationen, Tracheo/ Bronchoösophageale Fisteln, Unfallchirurgie, Kinderchirurgie, Gefäßchirurgie, Viszerale Palliativmedizin, Chronische Pankreatitis, Refluxerkrankungen

Gastroenterology,    Surgery

wikonect GmbH

The management of cholangiocarcinoma remains a major challenge. With the establishment of modern surgical, interventional and systemic treatment options over the last few years, the treatment of cholangiocarcinoma more than ever requires an interdisciplinary approach and open dialogue. Therefore, the 3rd International Expert Meeting in Mainz will bring together renowned specialists in the field of surgery, medical oncology, pathology, endoscopy, diagnostic and interventional radiology as well as radiotherapy. Experts from all around the world will meet in Mainz for an intensive two-day discussion on diverse aspects of cholangiocarcinoma. The program 2020 comprises most relevant topics and critical issues on the diagnosis and management of intrahepatic, perihilar as well as distal cholangiocarcinoma: as observed in other cancer types, molecular profiling has started to gain increasing relevance in the treatment of advanced cholangiocarcinoma. Moreover, novel diagnostic approaches as well as tools for local therapy have been developed, which require particular attention. Furthermore, controversies on the optimal preoperative work-up including biliary drainage as well as potential indications for neoadjuvant and adjuvant targeted therapy will be major topics. Also, IgG4-associated cholangitis and Klatskin-mimicking lesions that are still highly difficult differential diagnoses and pose major therapeutical problems will be highlighted. Finally, operative techniques, pitfalls in surgery and surgical strategies are presented focusing on vascular resection, the laparoscopic and robotic approach as well as ALPPS.

wikonect GmbH;     Phone: [+49 611 204 809 242];     Email: info@wikonect.de

Surgery,    Radiology (in general)

MCI Deutschland GmbH

Organizer;     Phone: [+49 30 204590];     Email: degro@mci-group.com

Ultra-High Dose Rates, Hypofractionation in curative therapy, Oligoma Tastasis, Synergies with Immunotherapy, Artificial Intelligence and Radiomics, MRI-guided Radiation Therapy, DEGRO: The First 25 Years; the next 25 years, Brachytherapy: Status and Development

European Association for Cancer Research & European Society of Oncologic Imaging

This new conference is organised by the European Association for Cancer Research (EACR) and the European Society of Oncologic Imaging (ESOI).Our ability to understand and treat cancer is critically dependent upon imaging. This meeting will bring together imaging experts in both clinical and basic research arenas to present their latest research and discuss how to integrate understanding across length scales, imaging modalities, and cancer types. Improved clinical imaging has the power to transform the detection and biologic characterisation of early lesions and the identification of those patients with more advanced disease for tailoring and monitoring personalised therapies. Further, the development of new therapies depends on improved understanding of cancer biology; small animal imaging and imaging tumours with cellular and sub-cellular resolution can elucidate heterogeneity in cancer cell state and interactions with stromal cells, which provide new opportunities for therapeutic intervention. This conference is aimed at clinical and experimental cancer researchers working with, or interested in, the broad range of imaging modalities including US and photoacoustic, CT and micro CT, MRI, PET/CT and PET/MR hybrid imaging, as well as optical techniques. Data analysts dealing with imaging data science using deep learning/machine learning, are also explicitly encouraged to attend.

Email: claire.sullivan@eacr.org

Imaging, Oncology, Machine Learning, Deep Learning, Cancer Biology, Personalised Therapies

Phone: [+4936413116390];     Email: conferencemarketing@conventus.de

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide hands-on experience in the several techniques to detect and analyse circulating tumor cells (CTCs), cell free tumor DNA (ctDNA) and proteins. Participants will have the opportunity to learn all aspects ranging from proper sampling through error free sequencing to data analysis. Lectures will also cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics.

EMBL Events;     Phone: [+49 6221 378 8797];     Email: events@embl.de

Hands-on experience on ultra-sensitive mutation detection using sequencing, Applications of digital PCR to the liquid biopsy workflow, Protein analysis in liquid biopsis, Data analysis and interpretations

Medicine (in general),    Analysis

Fraunhofer Institute for Cell Therapy and Immunology IZI and the University Cancer Center of the University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. This year’s conference will focus on tumor microenvironment, cell-based therapy in hematology and oncology, immune checkpoint inhibitors, biomarkers, cell therapies and cancer vaccines.

Fraunhofer Institute for Cell Therapy and Immunology;     Phone: [+49 341 35536-9320];     Email: info@lion-conference.com

oncology, immunology, hematology, biomarkers, immunotherapy, cell therapies, cancer vaccines

Immunology and Allergic Diseases,    Hematology

Phone: [+4936413116390];     Email: julia.wrenczycki@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de

Conventus Congressmanagement & Marketing GmbH

Email: conferencemarketing@conventus.de